Track topics on Twitter Track topics that are important to you
Regenerative medicines hold the ability to replace, repair, and regenerate tissues and organs that are affected due to some disease, injury, or natural ageing process. These medicines are capable of restoring the functionality of tissues amp; cells applicable in a wide range of degenerative disorders such as neurodegenerative diseases, dermatology, cardiovascular and orthopedic applications. Researchers have been focusing on the development of advanced technologies based on genes, biologics, somatic cells and stem cells. Stem cells have the capability to proliferate and differentiate owing to which they are of importance in this field. Currently, predominant treatments available for degenerative or lifethreatening diseases do not provide a treatment or are palliative; however, regenerative medicines have the ability to replace or regenerate the tissues and organs suffering from injury or disease. Moreover, the exploitation of nanomaterials in drug delivery, wound care and immunomodulation are opportunistic for the regenerative medicine market.nnThe growth of this market is attributed by the factors such as an emergence of stem cell technology, valuable potential of nanotechnology, rising prevalence of chronic diseases amp; trauma emergencies, innovation in monitoring devices and surgical technologies. Moreover, rising incidence of degenerative diseases specifically and shortage for organ transplants has boosted the market growth. Furthermore, the increasing focus on stem cells with new source, and getting core competency in the emerging economies are expected to supplement the growth in future. The developing nations are adopting technological advanced treatment modalities at a rapid pace, which is expected to assist in the market expansion worldwide. However, operational inefficiency, stringent regulations, and the high cost of the treatment through regenerative medicine deters the market progression.nnThe report segments the world regenerative medicine market based on product type, material, application, and geography. Based on product type, it is categorized into cell therapy, gene therapy, tissue engineering, and small molecules amp; biologics. Cell therapy dominated the market among all other products owing to its efficiency to restore the lost function of any tissue or organ. However, the small molecules amp; biologics segment is anticipated to grow at a highest CAGR of 34.2% from 2016 to 2022, due to its potential to stimulate dormant or endogenous cells to regain their regenerative properties.nnBased on material, the market is classified into synthetic materials, biologically derived materials, genetically engineered materials, and pharmaceuticals. The world regenerative medicine market is expected to reach $30,237 million by 2022 at a CAGR of 33.1% during 20162022. These materials are further subcategorized into different segments. The biologically derived materials accounted for about 4/7th of total market share in 2015, and is estimated to retain its position during the analysis period. The increasing demand for genetically engineered materials specially due to their unique properties such as promotion of increased proliferation, cellular interactions, and differentiation of cells that facilitates selfassembly into organized structures, and controlling the manipulation of cellular behavior.nnOn the basis of application, Regenerative medicine market is segmented as cardiovascular, oncology, dermatology, musculoskeletal, wound healing, ophthalmology, neurology, and others. The musculoskeletal application accounted for the largest share in 2015, whereas cardiovascular is expected to be the fastest growing segment at a CAGR of 35.3% during the analysis period.nnGeographically, the market is divided into North America, Europe, AsiaPacific, and LAMEA regions. North America is projected to dominate the overall market owing to the rising incidence of chronic disorders, growing demand for artificial organs due to the rise in the cases of organ failure, and presence of highly sophisticated healthcare infrastructure. AsiaPacific is projected to emerge as the region with maximum growth potential, with a CAGR of 39.9% during the forecast period, due to the presence of high unmet medical needs and persistently improving healthcare infrastructure. In addition, chief countries such as India, China, Australia and Japan contribute to the market growth due to high population base, rising demand for tissueengineered and regenerative medicine products. These countries have varying demographic and cultural conditions, which highly influence their respective markets.nnKey players operating in the regenerative medicine market include Stryker Corporation, Zimmer Biomet Holdings, Inc., Medtronic plc, Baxter International Inc., DePuy Synthes, Organogenesis Inc. Advanced Biohealing, Integra Lifesciences Holdings Corporation, Acelity Holdings, Inc., Ocata Therapeutics Inc. Astellas Pharma Inc., and CryoLife Inc.nnKey BenefitsnnnnThe report includes an extensive analysis of the factors driving as well as restraining the world regenerative medicine market.nnThe study provides an indepth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.nnThe report provides a quantitative analysis from 2014 to 2022 that is expected to enable the stakeholders to capitalize on prevailing market opportunities.nnExtensive analysis by product, material, application, and geography helps in understanding the various types of devices used for different chronic abnormalities.nnCompetitive intelligence highlights the business practices followed by leading market players across various geographic regions.nnnKey Market Segments:nnBY TECHNOLOGYnnnnCell TherapynnGene TherapynnTissue EngineeringnnSmall Molecules amp; BiologicsnnnBY MATERIALnnnnSynthetic MaterialsnnnnnnBiodegradable Synthetic PolymersnnnScaffoldnnnArtificial Vascular Graft MaterialsnnnHydrogel MaterialnnnnnnBiologically Derived MaterialsnnnnnCollagennnnXenogeneic MaterialnnnnnnGenetically Engineered MaterialsnnnnnDeoxyribonucleic Acid Transfection VectorsnnnGenetically Manipulated CellsnnnThreeDimensional Polymer TechnologynnnTransgenicnnnFibroblastsnnnNeural Stem CellsnnnGeneActivated MatricesnnnnnnPharmaceuticalsnnnnnSmall MoleculesnnnBiologicsnnnnnnnBY APPLICATIONnnnnCardiovascularnnOncologynnDermatologynnMusculoskeletalnnWound HealingnnOphthalmologynnNeurologynnOthersnnnBY GEOGRAPHYnnnnNorth AmericannnnnnU.S.nnnCanadannnMexiconnnnnnEuropennnnnGermanynnnUKnnnFrancennnItalynnnSpainnnnRussiannnRest of EuropennnnnnAsiaPacificnnnnnJapannnnChinannnIndiannnAustraliannnSouth KoreannnTaiwannnnRest of AsiaPacificnnnnnnLAMEAnnnnnBrazilnnnTurkeynnnVenezuelannnSaudi ArabiannnRepublic of South AfricannnRest of LAMEAnnnnn
Original Article: Regenerative Medicine Market by technology Cell Therapy, Gene Therapy, Tissue Engineering, Small Molecules Biologics, Material Biodegradable Synthetic Polymers, Scaffold, Artificial Vascular Graft Materials, Hydrogel Material, Collagen, Xenogeneic MateriNEXT ARTICLE
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...
Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...
Arthroplasty Joint Disorders Orthopedics Spinal Cord Disorders Orthopedics is the science or practice of correcting deformities caused by disease or damage to the bones and joints of the skeleton. This specialized branch of surgery may ...